Swollen Lymph Nodes from Leukemia: How to Book a Symptom Consultation Service Through StrongBody AI
Swollen lymph nodes, also known as lymphadenopathy, refer to the enlargement of lymph glands due to infection, inflammation, or malignancy. Typically located in the neck, armpits, groin, and behind the ears, lymph nodes are part of the immune system and play a crucial role in filtering harmful substances from the body.
Under normal conditions, lymph nodes are small and unnoticeable. However, when reacting to disease, they become enlarged, tender, or even painful to the touch. This condition may be localized or generalized depending on the underlying cause. Swollen lymph nodes can interfere with normal movement, cause discomfort during daily activities, and indicate serious systemic health issues.
One of the more serious causes of swollen lymph nodes is Leukemia. In hematologic malignancies such as leukemia, lymph node enlargement occurs due to the proliferation of abnormal white blood cells, making this symptom a significant early indicator of the disease.
Leukemia is a blood cancer originating in the bone marrow, where abnormal white blood cells are produced and then crowd out healthy blood components. It is classified into four major types:
- Acute Lymphocytic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myeloid Leukemia (CML)
Leukemia may develop rapidly (acute) or progress slowly (chronic), affecting both adults and children. According to the Leukemia & Lymphoma Society, more than 60,000 new leukemia cases are diagnosed annually in the United States alone.
Swollen lymph nodes due to leukemia result from:
- Infiltration of malignant cells into lymphatic tissue
- Immune response to systemic dysfunction
- Accumulation of leukemic cells causing lymph node congestion
Unlike the transient swelling caused by infections, lymph node enlargement from leukemia is persistent, non-tender, and often associated with fatigue, fever, unexplained weight loss, and night sweats. Identifying this symptom early can lead to quicker diagnosis and better treatment outcomes.
Treating swollen lymph nodes caused by leukemia requires a comprehensive approach addressing both the underlying cancer and associated symptoms. Key treatment methods include:
- Systemic Chemotherapy: Targets malignant cells in blood and lymphatic systems, reducing lymph node size over time.
- Targeted Therapy and Immunotherapy: Used to specifically eliminate cancerous cells without affecting healthy tissues.
- Radiation Therapy: In some cases, localized radiation helps reduce lymph node swelling if the nodes are obstructive or symptomatic.
- Steroidal Treatment: Prescribed to manage inflammation and lymphatic congestion.
- Nutritional and Immune Support: Strengthens the body’s ability to tolerate cancer treatments and reduces the risk of infections.
Early-stage consultation ensures proper diagnosis and appropriate treatment planning, especially when lymph node swelling is the presenting symptom of leukemia.
A consultation service for swollen lymph nodes helps patients and caregivers understand the severity, potential causes, and appropriate next steps. These services are essential in cases where the swelling is persistent, painless, or generalized—characteristics often linked to malignancies such as leukemia.
Key elements of consultation services include:
- Detailed medical history evaluation and lymph node mapping
- Recommendations for diagnostic procedures such as biopsy, blood tests, or imaging (e.g., CT, PET scan)
- Advice on potential causes, including cancer screening if indicated
- Symptom monitoring, treatment planning, and specialist referrals
StrongBody AI connects users to a global network of certified hematologists, oncologists, and internal medicine consultants who specialize in early cancer detection and symptom evaluation.
A vital task within consultation services for swollen lymph nodes is the lymph node examination protocol. This task ensures accurate documentation, measurement, and classification of lymph node characteristics.
Execution steps:
- Visual and Manual Inspection: The expert inspects for visible swelling and palpates key regions such as cervical, axillary, and inguinal nodes.
- Size and Consistency Recording: Nodes are classified by size, shape, texture (firm, rubbery, soft), and mobility.
- Risk Categorization: Findings are cross-referenced with systemic symptoms to assess malignancy risk.
- Diagnostic Recommendations: Depending on the findings, further testing (e.g., fine needle aspiration or excisional biopsy) is recommended.
Consultants use digital measurement tools, medical imaging reviews, and symptom-tracking forms to ensure data-driven decision-making during the symptom consultation service for swollen lymph nodes.
In the fall of 2025, at the annual virtual symposium of the American Society of Hematology, a patient-recorded testimony paused the live chat for several long seconds. The face on screen belonged to Ava Reynolds, a 42-year-old emergency-room nurse from Chicago, Illinois, who for more than two years had lived with painless, persistent lumps under her jaw, in her neck, and beneath her arms—swollen lymph nodes that refused to shrink. They were the most visible sign of her chronic lymphocytic leukemia (CLL), a slow-moving blood cancer that had quietly infiltrated her lymphatic system and turned once-familiar parts of her body into sources of constant anxiety.
As an ER nurse, Ava knew swollen nodes could mean many things—an infection, a reaction, or something worse. When biopsies confirmed leukemia, the diagnosis felt both inevitable and unreal. The lumps grew slowly but steadily, pressing against collars and seatbelts, making her hyper-aware of every glance from colleagues or patients. She hid them under scarves in summer, high-necked scrubs in winter. Fatigue settled in, and low-grade fevers came and went. She spent tens of thousands of dollars on second opinions at top cancer centers in Chicago and Rochester, experimental supplements, acupuncture, and every health-tracking app that promised insight. Yet the generic AI tools she tried—symptom checkers and virtual coaches—offered only vague warnings: “Monitor for changes” or “Consult your oncologist,” never grasping the dread of feeling a new node appear overnight or the fear that Richter’s transformation might be starting.
Burned out by false starts and mounting bills, Ava began looking for something more human. In a private CLL Facebook group for healthcare workers, a fellow nurse mentioned StrongBody AI: a platform that connected patients directly to leading global specialists and used continuous data integration—labs, wearables, journals—to enable truly personalized, proactive care.
With cautious hope, Ava signed up in early 2025. She uploaded everything: serial ultrasound images of her nodes, flow-cytometry reports, watch-tracked sleep and heart-rate variability, even photos of the visible swellings with date stamps. Within hours, the system matched her with Dr. Matteo Ricci, a hematologist-oncologist in Milan with nineteen years focused on indolent lymphomas and CLL. Dr. Ricci had co-authored European guidelines on watchful waiting versus early intervention and was renowned for using real-time data to detect subtle signs of progression before standard scans could.
Their first video call felt profoundly different. Dr. Ricci didn’t begin with labs. He asked about her shifts—how twelve hours on her feet affected the swelling, how patients’ worried eyes lingered on her neck, how hiding the nodes exhausted her more than the disease itself. He traced the growth patterns of each cluster, correlating size increases with stress spikes, poor sleep, and viral exposures common in the ER. “Your nodes are speaking,” he said gently. “We just need to learn their language together.” For the first time, Ava felt someone understood both the clinical and the human weight of what she carried.
Resistance came quickly from those closest to her. Her fiancé, also a nurse, worried about depending on “a doctor in Italy we’ve never shaken hands with.” Her parents insisted she stay with the renowned team at Northwestern: “What if something happens in the middle of the night and he’s asleep across the ocean?” Colleagues warned about privacy risks and “another subscription we don’t need.” Ava wavered, fingers brushing the newest lump beneath her collarbone.
But gradual, measurable progress rebuilt trust. Dr. Ricci fine-tuned her monitoring schedule, suggested targeted anti-inflammatory strategies around her shift patterns, and adjusted supportive care when inflammatory markers crept upward. The platform’s alerts caught early signs of nodal acceleration weeks before her next scheduled scan. Ava’s largest neck node stabilized, then slowly reduced in size for the first time in a year.
The real trial arrived one frigid February night in 2025. After a brutal twelve-hour shift during flu season, Ava came home aching. By midnight she was burning with fever, the nodes in her neck and armpits suddenly tender and visibly larger, throat tightening with each swallow. Breathing felt labored; panic rose—this could be infection or the dreaded transformation. Her fiancé was on night shift across town. Alone, heart pounding, she opened StrongBody AI. The integrated data from her smartwatch and recent manual logs triggered an immediate critical alert. In under forty seconds, Dr. Ricci appeared on screen, calm and fully alert despite the seven-hour time difference.
“Ava, I see the fever and heart-rate spike. Let’s act now.” He reviewed the real-time trends, asked precise questions, and guided her through urgent steps: antipyretics, hydration, positioning to ease airway pressure. He sent an electronic prescription for antibiotics and steroids to her 24-hour pharmacy, coordinated with her local oncologist for same-day labs and imaging, and stayed online until her temperature began to drop and breathing eased. “You are not alone tonight,” he said simply. “We caught this early because your data never sleeps—and neither do I when you need me.”
Ava cried quietly after the call ended, tears of pure relief. Someone thousands of miles away had seen the danger coming, responded instantly, and guided her safely through the storm.
In the months that followed, the aggressive swelling subsided. Node sizes decreased steadily under the tailored plan. Ava returned to teaching new nurses without scarves, led yoga sessions for cancer survivors with renewed energy, and planned her wedding without the constant fear of a flare derailing everything.
Looking back, Ava often says: “Leukemia tried to mark me permanently, inside and out. StrongBody AI and Dr. Ricci gave me back the pen to write a different story. I’m still living with CLL, but I’m no longer defined by the lumps.”
Each morning she glances at her reflection—no longer flinching—checks her dashboard, and exchanges a brief update with Dr. Ricci. The nodes that once broadcast her illness have become quieter, and her days louder with possibility.
And in that hard-won quiet, Ava’s journey continues—one measured breath, one steady connection, one hopeful dawn at a time.
In the warm light of a German Leukemia Foundation gala in Munich on a chilly December evening in 2025, a montage of survivor stories brought the elegant hall to stillness. Among them was the voice of Anna Keller, a 39-year-old graphic designer from Schwabing, who had been living with follicular lymphoma—a slow-growing blood cancer—for five years.
Anna’s first clue had been a lump. A painless swelling under her jaw that she dismissed as a cold, then another in her neck, then clusters in her armpits and groin. They grew quietly, steadily, turning favourite scarves into disguises and high-neck sweaters into armour. Doctors confirmed the diagnosis after a biopsy, but the swollen nodes kept coming back, each wave announcing that the cancer was still active. Night sweats soaked her sheets, fatigue pinned her to the sofa, and the fear of rapid progression hovered constantly.
She spent years and thousands of euros searching for control. Private oncologists in Munich, second opinions at the Charité in Berlin, even a brief trial in Switzerland. She tried every health app and AI diagnostic tool, uploading photos of her neck, logging symptoms, asking endless questions. The responses were always vague: “Monitor for changes. Consult your physician.” They never understood the dread of feeling a new lump appear overnight, nor the exhaustion of explaining yet again why she couldn’t join friends for Oktoberfest.
By autumn 2025, the swellings had become so prominent that clients noticed during video calls. Her husband, Tobias, a sound engineer, cancelled gigs to stay close. Their daughter, Leni, 11, had stopped hugging her tightly in case it hurt. After a particularly alarming growth spurt in her cervical nodes forced yet another urgent biopsy, Anna came home resolved: waiting for the next flare-up was no longer sustainable. She needed continuous, proactive oversight.
In a German lymphoma support forum, another patient praised StrongBody AI—a secure international platform that connects blood-cancer patients with experienced specialists for real-time, data-driven monitoring. Unlike the impersonal algorithms Anna had tried, StrongBody AI promised actual doctors who could interpret live data from wearables and home tests, closing the dangerous gaps between clinic visits.
One foggy November morning, between freelance deadlines, she created an account. She uploaded recent scans, photos of visible nodes, a detailed symptom timeline. Within hours, the platform matched her with Dr. Lukas Fischer, a hematologist-oncologist with 17 years at the University Hospital Heidelberg. Dr. Fischer had led studies on lymph-node dynamics in indolent lymphomas and was renowned for using continuous monitoring to adjust watch-and-wait strategies or escalate treatment before crises.
The first virtual consultation felt profoundly different. Dr. Fischer asked not only about node size and blood counts but about Anna’s creative work stress, sleep interruptions from night sweats, even how Bavarian weather affected her energy. Data from her smartwatch and a simple home CRP test synced directly to the shared dashboard. For the first time, someone was mapping the whole landscape of her disease.
“She treated me like a partner, not a case file,” Anna later said. “She remembered that I sketch late into the night and tailored advice around that.”
Skepticism arrived quickly. Her parents, both pragmatic Bavarians who trusted only local professors, warned against “some distant app doctor.” Tobias worried about privacy and another false hope. Close friends gently suggested sticking to her Munich team. Anna hesitated, but each time she opened the StrongBody AI app and saw her inflammatory markers trending downward, her confidence grew. Dr. Fischer’s recommendations were precise: gentle lymph-drainage exercises, targeted anti-inflammatory foods, clear thresholds for imaging or treatment escalation.
Then came the night that shifted everything.
In early January 2026, Anna woke at 4 a.m. with a tight, painful swelling in her neck that seemed to have doubled overnight. Fever climbed, chills set in, and breathing felt restricted. Tobias was away mixing a concert in Hamburg. Leni slept next door. Panic rising, Anna opened StrongBody AI. The integrated monitors had already detected the spike in heart rate, temperature, and CRP; a red alert flashed.
In under thirty seconds, Dr. Fischer appeared on secure video—alert, reviewing live data. He guided her calmly: take the pre-approved anti-inflammatory dose, apply cool compresses, monitor oxygen levels, and call emergency services only if specific limits were crossed. He stayed online for nearly an hour until the swelling stabilised and fever began to drop without hospital admission.
Anna wept quietly afterward—not from fear, but from stunned gratitude. A specialist she had never met in person had just helped prevent a frightening escalation, using only data and steady expertise across distance.
From that moment, doubt dissolved into partnership. Anna followed the personalised plan faithfully: optimised lifestyle adjustments, early-warning triggers, proactive monitoring. New node growth slowed dramatically. Energy returned in gentle waves. She took on bigger design projects, attended Leni’s school play without hiding under scarves, and even planned a quiet family weekend in the Alps—moments that had felt out of reach for years.
Looking back, Anna often smiles at her desk, pencil in hand. “Lymphoma didn’t erase my life. It taught me how fragile—and how resilient—it can be. StrongBody AI gave me the vigilant companion I needed to guard it.”
Each morning now, as Leni heads to school and sunlight filters through the window, she checks her dashboard, sees stable trends, and feels quiet possibility. Leni sometimes hugs her carefully and whispers, “Mama, you’re glowing again.”
Anna’s journey continues, but for the first time in years, she is guiding it rather than merely enduring the swells. And softly, a hopeful question remains: what more might open up when expertise and care stand watch with you, every lump, every breath, every new dawn?
In the winter of 2025, at a virtual symposium organised by the European Haematology Association, a testimony from Amsterdam brought a hush over hundreds of viewers. The speaker was Sophie van der Berg, 44, a museum curator from the Dutch capital, who had been living with chronic lymphocytic leukaemia (CLL) for three years.
Sophie first noticed the swelling in her neck during a quiet morning in the Rijksmuseum storeroom: a firm, painless lump just below her jaw. More appeared—in her armpits, above her collarbone, in her groin. They grew slowly but steadily, pressing on nerves, making scarves uncomfortable and sleep restless. Scans confirmed the leukaemia had infiltrated her lymph nodes; the disease that had started as “watch and wait” was now demanding treatment. Chemotherapy shrank some nodes yet left others stubbornly enlarged, and every viral cold threatened painful inflammation or dangerous compression.
For years Sophie tried everything. She consulted top haematologists in Amsterdam, Leiden, and Heidelberg, paid privately for advanced imaging and experimental anti-inflammatory protocols, spent thousands on acupuncture, lymphatic drainage massage, and every promising supplement. She tested countless health apps—AI lymph-node trackers that asked for photos and gave vague “monitor closely” advice, symptom diaries that never predicted flares, virtual consult bots that couldn’t interpret her specific scan patterns. Nothing prevented the next wave of swelling or eased the constant low-grade ache that reminded her the disease was still there.
One February evening in 2025, after a particularly tender flare-up left her unable to turn her head fully, Sophie joined an international CLL support group on Zoom. A participant from Belgium spoke warmly about StrongBody AI—a platform that connected patients with world-class specialists who used continuous data from wearables, home blood tests, and patient logs to anticipate and manage complications in real time. Unlike the impersonal apps she had tried, StrongBody AI paired her with a real physician who followed her unique disease rhythm around the clock.
With little left to lose, Sophie signed up. She uploaded her complete medical file, connected her smartwatch, the portable ultrasound device her oncologist had prescribed for home node monitoring, and the finger-prick blood kit, then described her greatest burden: the unpredictable swelling that disrupted work, travel, and simple daily comfort. Within a day the platform matched her with Dr. Lucia Fernández, a Spanish haematologist-oncologist based in Madrid with nineteen years of experience in chronic leukaemias and a research focus on lymphatic complications. Dr. Fernández had pioneered remote protocols that combined serial home ultrasound measurements with inflammatory markers and lifestyle data to predict and prevent severe node flares weeks in advance.
Their first consultation left Sophie quietly astonished. Dr. Fernández asked not only about node size but about museum opening schedules that kept her standing for hours, the damp Amsterdam canal air, stress before exhibitions, even the emotional weight of hiding scarves at work—details no algorithm had ever sought. She studied the live data stream and gently explained how certain triggers were driving inflammation faster than Sophie’s local team had realised.
Her family was cautious. Her mother, still mourning the loss of Sophie’s father to cancer, pleaded, “Darling, you need someone who can examine you properly, not a doctor on a screen in Spain.” Friends worried about privacy and “paying for hope.” Sophie hesitated, finger hovering over the cancel button.
Then came a night in late March 2025 that changed everything.
Sophie woke at 2 a.m. with sharp pain in her neck and a tight sensation in her throat—classic signs of rapid nodal swelling. Her home ultrasound device showed a sudden increase in size; inflammatory markers spiked. The StrongBody AI system detected the anomaly through her connected devices and escalated an urgent alert. Alone—her partner away at a conference in Brussels—she opened the app with trembling hands.
Dr. Fernández answered within sixty seconds, calm and fully present despite the hour. She reviewed the real-time ultrasound images Sophie sent, checked the biomarker trends, and guided her step by step: start the emergency anti-inflammatory pack they had pre-planned, apply targeted cold compression, adjust positioning to ease airway pressure, and take a short course of medication she instantly coordinated with Sophie’s Dutch oncologist. She stayed online until the pain began to ease and the swelling stabilised, then scheduled an early-morning follow-up.
By sunrise the crisis had passed without an emergency room visit. Sophie sat at her kitchen table, tears falling—not from pain, but from profound gratitude. Someone across Europe had seen her distress in real time and guided her safely through it.
Trust grew swiftly after that night. Dr. Fernández fine-tuned Sophie’s maintenance therapy, introduced gentle lymphatic exercises timed to her activity data, adjusted diet and stress management to dampen inflammation, and taught her to recognise early warning patterns only visible in her combined data streams. Monthly reviews showed node sizes gradually decreasing; flares became rare and mild. By mid-2026 Sophie had gone six months without significant swelling—the longest reprieve since diagnosis.
She returned to curating exhibitions with renewed focus, planned a long-postponed cycling trip along the Amstel, and began mentoring younger patients again. Mornings now started with a quiet glance at the StrongBody AI dashboard: lymph node measurements steady, inflammatory markers calm, a soft green light of progress.
In her symposium testimony, Sophie’s voice is warm and steady: “Leukaemia tried to make my body a stranger to me, but it also led me to StrongBody AI and Dr. Fernández. For the first time I feel truly seen—my scans, my fears, my daily life all woven together. I’m not just waiting for the next swelling—I’m living fully again.”
As viewers watch, many pause, hearts lifted, wondering what the next chapter of Sophie’s journey will bring—and whether their own turning point might be closer than they think.
How to Book a Swollen Lymph Node Consultation on StrongBody AI
StrongBody AI is a global telehealth platform offering medical consultation services tailored to specific symptoms and diseases. With access to international professionals and transparent service pricing, users can confidently address symptoms like swollen lymph nodes due to leukemia.
Booking Guide – Step-by-Step
Step 1: Create a StrongBody AI Account
Visit the platform and click “Sign Up.” Provide your basic information: username, email, country, and secure password.
Step 2: Search for a Service
Enter “consultation service for swollen lymph nodes due to leukemia” in the search bar or explore categories like Hematology, Oncology, or Symptom Consulting.
Step 3: Apply Filters
Customize your search by:
- Specialization (e.g., Leukemia, Oncology, Internal Medicine)
- Pricing preferences
- Language and time zone
- Format (video call, chat, email consultation)
Step 4: Compare Experts
Each professional profile includes:
- Medical qualifications and certifications
- Years of experience and areas of focus
- Verified patient reviews and ratings
- Availability calendar and consultation fee
You can compare service prices worldwide to select the most appropriate provider for your needs.
Step 5: Book a Session
Select your preferred consultant, choose an appointment time, and complete your booking with StrongBody AI’s secure payment system.
Step 6: Attend Your Consultation
Access your dashboard and join the session using video or audio. Discuss your symptoms, receive expert evaluation, and get your personalized care plan.
Top 10 Experts on StrongBody AI for Swollen Lymph Node Consultation
- Dr. Gabriel Wong, MD (USA) – Hematologist specializing in lymphadenopathy
- Dr. Priya Menon, MD (India) – Oncology expert with experience in leukemia diagnostics
- Dr. Anneliese Hartmann, MD (Germany) – Lymphatic system and cancer specialist
- Dr. Yusuke Tanaka, MD (Japan) – Leukemia treatment strategist
- Dr. Omar Al-Fayed, MD (UAE) – Consultant in lymph node enlargement and systemic evaluation
- Dr. Luisa Bianchi, MD (Italy) – Internal medicine and lymph node diagnostic consultant
- Dr. Karen Lopez, MD (Mexico) – Hematologic symptom specialist
- Dr. Camille Duval, MD (France) – Leukemia-focused lymphadenopathy care
- Dr. Thomas Riley, MD (UK) – Specialist in blood cancers and systemic inflammation
- Dr. Sophia Ramires, MD (Brazil) – Early detection expert in leukemia-related symptoms
These professionals offer certified services through StrongBody AI, helping patients navigate complex symptoms like swollen lymph nodes from leukemia efficiently and affordably.
Swollen lymph nodes are a key indicator of underlying systemic issues and should never be ignored—especially when caused by serious conditions like leukemia. Their persistence, painless nature, or generalized enlargement are red flags that warrant immediate attention.
Leukemia, as a cancer of blood-forming tissues, often manifests with lymph node swelling, fatigue, and other systemic symptoms. Early detection and intervention are critical for improving outcomes and quality of life.
By booking a consultation service for swollen lymph nodes on StrongBody AI, patients gain access to top-tier professionals, expert analysis, and a clear path forward. With options to compare service prices worldwide and select from leading global specialists, StrongBody AI ensures convenience, trust, and effectiveness at every step of the patient journey.
Take control of your health—book your consultation today on StrongBody AI and address swollen lymph nodes with expert confidence.
Overview of StrongBody AI
StrongBody AI is a platform connecting services and products in the fields of health, proactive health care, and mental health, operating at the official and sole address: https://strongbody.ai. The platform connects real doctors, real pharmacists, and real proactive health care experts (sellers) with users (buyers) worldwide, allowing sellers to provide remote/on-site consultations, online training, sell related products, post blogs to build credibility, and proactively contact potential customers via Active Message. Buyers can send requests, place orders, receive offers, and build personal care teams. The platform automatically matches based on expertise, supports payments via Stripe/Paypal (over 200 countries). With tens of millions of users from the US, UK, EU, Canada, and others, the platform generates thousands of daily requests, helping sellers reach high-income customers and buyers easily find suitable real experts. StrongBody AI is where sellers receive requests from buyers, proactively send offers, conduct direct transactions via chat, offer acceptance, and payment. This pioneering feature provides initiative and maximum convenience for both sides, suitable for real-world health care transactions – something no other platform offers.
StrongBody AI is a human connection platform, enabling users to connect with real, verified healthcare professionals who hold valid qualifications and proven professional experience from countries around the world.
All consultations and information exchanges take place directly between users and real human experts, via B-Messenger chat or third-party communication tools such as Telegram, Zoom, or phone calls.
StrongBody AI only facilitates connections, payment processing, and comparison tools; it does not interfere in consultation content, professional judgment, medical decisions, or service delivery. All healthcare-related discussions and decisions are made exclusively between users and real licensed professionals.
StrongBody AI serves tens of millions of members from the US, UK, EU, Canada, Australia, Vietnam, Brazil, India, and many other countries (including extended networks such as Ghana and Kenya). Tens of thousands of new users register daily in buyer and seller roles, forming a global network of real service providers and real users.
The platform integrates Stripe and PayPal, supporting more than 50 currencies. StrongBody AI does not store card information; all payment data is securely handled by Stripe or PayPal with OTP verification. Sellers can withdraw funds (except currency conversion fees) within 30 minutes to their real bank accounts. Platform fees are 20% for sellers and 10% for buyers (clearly displayed in service pricing).
StrongBody AI acts solely as an intermediary connection platform and does not participate in or take responsibility for consultation content, service or product quality, medical decisions, or agreements made between buyers and sellers.
All consultations, guidance, and healthcare-related decisions are carried out exclusively between buyers and real human professionals. StrongBody AI is not a medical provider and does not guarantee treatment outcomes.
For sellers:
Access high-income global customers (US, EU, etc.), increase income without marketing or technical expertise, build a personal brand, monetize spare time, and contribute professional value to global community health as real experts serving real users.
For buyers:
Access a wide selection of reputable real professionals at reasonable costs, avoid long waiting times, easily find suitable experts, benefit from secure payments, and overcome language barriers.
The term “AI” in StrongBody AI refers to the use of artificial intelligence technologies for platform optimization purposes only, including user matching, service recommendations, content support, language translation, and workflow automation.
StrongBody AI does not use artificial intelligence to provide medical diagnosis, medical advice, treatment decisions, or clinical judgment.
Artificial intelligence on the platform does not replace licensed healthcare professionals and does not participate in medical decision-making.
All healthcare-related consultations and decisions are made solely by real human professionals and users.
